Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d'Etude Des Lymphomes De l'Adulte

Ghesquieres, H., Van Den Neste, E., Ferlay, C., Bajard, A., Sebban, C., Perol, D., Bosly, A., Casasnovas, O., Reman, O., Coiffier, B., Tilly, H., Morel, P., De Prijck, B., Colin, P., Ketterer, N., Antoine, T., Delannoy, A., Haioun, C., Devidas, A., et al. (2009). Complete Response After High-Dose Methotrexate-Based Chemotherapy as a Major Prognostic Factor for Primary CNS Lymphoma: An Exploratory Analysis of the LNHCP93 Trial of the Groupe d’Etude Des Lymphomes De l’Adulte. Blood, 114(22), 46-47. https://hdl.handle.net/2078.5/71121 (Original work published 2009)